Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
McKesson
Accenture
Chinese Patent Office
Argus Health
Healthtrust
Julphar
QuintilesIMS
Queensland Health

Generated: January 23, 2018

DrugPatentWatch Database Preview

PINDOLOL Drug Profile

« Back to Dashboard

When do Pindolol patents expire, and when can generic versions of Pindolol launch?

Pindolol is a drug marketed by G And W Labs Inc, Idt Australia Ltd, Mylan Pharms Inc, Nostrum Labs, Nostrum Labs Inc, Purepac Pharm, Sun Pharm Industries, Watson Labs, and Zydus Pharms Usa Inc. and is included in fourteen NDAs.

The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pindolol profile page.

US Patents and Regulatory Information for PINDOLOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc PINDOLOL pindolol TABLET;ORAL 073661-001 Oct 31, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm PINDOLOL pindolol TABLET;ORAL 074125-002 Apr 28, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc PINDOLOL pindolol TABLET;ORAL 209866-002 Aug 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Idt Australia Ltd PINDOLOL pindolol TABLET;ORAL 073608-001 Mar 29, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
G And W Labs Inc PINDOLOL pindolol TABLET;ORAL 073661-002 Oct 31, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc PINDOLOL pindolol TABLET;ORAL 074019-002 Sep 3, 1992 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries PINDOLOL pindolol TABLET;ORAL 074063-002 Jan 27, 1994 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Idt Australia Ltd PINDOLOL pindolol TABLET;ORAL 073609-001 Mar 29, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries PINDOLOL pindolol TABLET;ORAL 074063-001 Jan 27, 1994 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nostrum Labs Inc PINDOLOL pindolol TABLET;ORAL 205415-002 Jan 13, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
Teva
Medtronic
Federal Trade Commission
US Army
US Department of Justice
Mallinckrodt
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot